Mammography Screening Intervals May Affect Breast Cancer Prognosis
By MedImaging International staff writers Posted on 02 Jan 2014 |
Image: Bilateral mediolateral oblique (MLO) views from screening mammography in a 53-year-old woman (Photo courtesy of RSNA).
Image: Spot magnification view demonstrates an irregular spiculated mass with associated calcifications in the upper outer left breast. Ultrasound biopsy revealed invasive ductal carcinoma and DCIS (Photo courtesy of RSNA).
Image: Screening mammogram in a 63-year-old woman demonstrated calcifications in the upper outer left breast. Bilateral craniocaudal (CC) views shown (Photo courtesy of RSNA).
In a study of screening mammography-detected breast tumors, patients who had more frequent screening mammography exams had a considerably lower rate of lymph node positivity as compared to women who had longer intervals between screening-mammography exams.
The study’s findings were presented December 3, 2013, at the annual meeting of the Radiological Society of North America (RSNA), held December 2013 in Chicago (IL, USA). In its earliest stages, breast cancer is confined to the breast and can be treated by surgically removing the cancer cells. Breast cancer cells may metastasize to the lymph nodes as the disease progresses and then to other areas of the body.
“On its pathway to other places in the body, the first place breast cancer typically drains into before metastasizing is the lymph nodes,” said Lilian Wang, MD, assistant professor of radiology at Northwestern University/Feinberg School of Medicine (Chicago, IL, USA). “When breast cancer has spread into the lymph nodes, the patient is often treated both locally and systemically, with either hormone therapy, chemotherapy, trastuzumab, or some combination of these therapies.”
Healthcare organizations, such as RSNA and the American Cancer Society (ACS), have recommended yearly screening with mammography for women beginning at age 40. However, in 2009, the United States Preventive Services Task Force (USPSTF) announced a controversial new recommendation for biennial screening for women between the ages of 50 and 74. “Our study looks at what would happen if the revised guidelines issued by USPSTF were followed by women,” Dr. Wang said.
Conducted at Northwestern Memorial Hospital (Chicago, IL, USA), the retrospective study, included 332 women with breast cancer identified by screening mammography between 2007 and 2010. The women were split into one of three groups, based on the length of time between their screening mammography exams: less than 1.5 years, 1.5 to three years, and more than three years. There were 207, 73, and 52 patients in each category, respectively.
The researchers determined, controlling for age, breast density, high-risk status, and a family history of breast cancer, that women in the less than 1.5-year interval group had the lowest lymph node positivity rate at 8.7%. The rate of lymph node involvement was substantially higher in the 1.5- to three-year and over three-year interval groups at 20.5% and 15.4%, respectively.
“Our study shows that screening mammography performed at an interval of less than 1.5 years reduces the rate of lymph node positivity, thereby improving patient prognosis,” Dr. Wang concluded. “We should be following the guidelines of the American Cancer Society and other organizations, recommending that women undergo annual screening mammography beginning at age 40.”
Related Links:
Northwestern University/Feinberg School of Medicine
The study’s findings were presented December 3, 2013, at the annual meeting of the Radiological Society of North America (RSNA), held December 2013 in Chicago (IL, USA). In its earliest stages, breast cancer is confined to the breast and can be treated by surgically removing the cancer cells. Breast cancer cells may metastasize to the lymph nodes as the disease progresses and then to other areas of the body.
“On its pathway to other places in the body, the first place breast cancer typically drains into before metastasizing is the lymph nodes,” said Lilian Wang, MD, assistant professor of radiology at Northwestern University/Feinberg School of Medicine (Chicago, IL, USA). “When breast cancer has spread into the lymph nodes, the patient is often treated both locally and systemically, with either hormone therapy, chemotherapy, trastuzumab, or some combination of these therapies.”
Healthcare organizations, such as RSNA and the American Cancer Society (ACS), have recommended yearly screening with mammography for women beginning at age 40. However, in 2009, the United States Preventive Services Task Force (USPSTF) announced a controversial new recommendation for biennial screening for women between the ages of 50 and 74. “Our study looks at what would happen if the revised guidelines issued by USPSTF were followed by women,” Dr. Wang said.
Conducted at Northwestern Memorial Hospital (Chicago, IL, USA), the retrospective study, included 332 women with breast cancer identified by screening mammography between 2007 and 2010. The women were split into one of three groups, based on the length of time between their screening mammography exams: less than 1.5 years, 1.5 to three years, and more than three years. There were 207, 73, and 52 patients in each category, respectively.
The researchers determined, controlling for age, breast density, high-risk status, and a family history of breast cancer, that women in the less than 1.5-year interval group had the lowest lymph node positivity rate at 8.7%. The rate of lymph node involvement was substantially higher in the 1.5- to three-year and over three-year interval groups at 20.5% and 15.4%, respectively.
“Our study shows that screening mammography performed at an interval of less than 1.5 years reduces the rate of lymph node positivity, thereby improving patient prognosis,” Dr. Wang concluded. “We should be following the guidelines of the American Cancer Society and other organizations, recommending that women undergo annual screening mammography beginning at age 40.”
Related Links:
Northwestern University/Feinberg School of Medicine
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection